Genomma Lab Internacional
Genomma Lab Internacional, a leading player in the pharmaceutical and personal care industry, is headquartered in Mexico (MX) and operates extensively across Latin America and the United States. Founded in 2000, the company has achieved significant milestones, including rapid expansion and a diverse product portfolio that encompasses over-the-counter medications, skincare, and dietary supplements. Renowned for its innovative approach, Genomma Lab offers unique formulations that cater to various health and wellness needs, setting it apart in a competitive market. With a strong commitment to quality and research, the company has established a solid market position, recognised for its effective solutions and consumer trust. Genomma Lab Internacional continues to thrive, driven by its dedication to enhancing the well-being of its customers.
DitchCarbon Score
How does Genomma Lab Internacional's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genomma Lab Internacional's score of 39 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Genomma Lab Internacional's reported carbon emissions
In 2023, Genomma Lab Internacional reported total carbon emissions of approximately 44,075,120 kg CO2e, with 3,100,840 kg CO2e from Scope 1, 4,740,490 kg CO2e from Scope 2, and the remaining emissions from Scope 3. This marks a significant increase in emissions compared to previous years, reflecting the company's growth and operational scale. In 2022, the company emitted about 43,466,980 kg CO2e, with Scope 1 emissions at 2,737,470 kg CO2e and Scope 2 at 4,041,110 kg CO2e. The trend indicates a rising trajectory in emissions, particularly in Scope 3, which encompasses indirect emissions from the supply chain and product use. Genomma Lab has not publicly disclosed specific reduction targets or initiatives aimed at decreasing its carbon footprint. The absence of documented reduction strategies suggests a need for enhanced climate commitments within the organisation. As the company continues to expand, addressing its carbon emissions will be crucial for aligning with global climate goals and improving sustainability practices.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 198,500 | 000,000 | 00,000 | 0,000,000 | 0,000,000 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 570,700 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 0,000,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Genomma Lab Internacional is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
